TORRINGTON, Conn., April 24, 2025 /PRNewswire/ — Therap Services is enhancing its medication management capabilities with the introduction of the new Drug Count feature on the Individual Home Page. This update is designed to support provider agencies in Long-Term Services and Supports (LTSS), Home and Community-Based Services (HCBS), and the broader human services sector by simplifying the process of tracking and documenting medication counts in a centralized, secure environment.
Streamlined and Person-Centered Medication Management
Therap’s new Drug Count feature allows care providers to record or search for Drug Counts directly from the ‘Modules’ section of the Individual Home Page. Users with the ‘Medication History Count’ role can access the ‘New’ and ‘Search’ links, streamlining medication tracking. This enhancement supports Therap’s commitment to HIPAA-compliant electronic documentation.
The Individual Home Page offers a unified interface for accessing person-centered information, including demographics, support plans, health data, incident reports, and activities, enabling care teams to efficiently manage and document everything in one place.
Key Benefits of Therap’s Drug Count Feature
Medication Management Solution
Therap’s Drug Count feature is more than just an enhancement—it’s a solution that empowers care providers to manage medication counts efficiently while maintaining high standards of care and compliance. By simplifying documentation, improving access to information, and fostering seamless communication among care providers, Therap continues to support providers in delivering quality and person-centered care.
Learn More
To explore more about Therap’s Person-Centered care, visit:
About Therap
Therap’s comprehensive and HIPAA-compliant software is used in human services settings for documentation, communication, reporting, EVV and billing.
Related Links:
https://www.therapservices.net/
SOURCE Therap Services
12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel…
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…
The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…
MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:…
TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…